Active substancePyracetamPyracetam
Similar drugsTo uncover
  • Lucetam®
    solution w / m in / in 
  • Lucetam®
    pills inwards 
  • Memotropil®
    pills inwards 
  • Nootropil®
    capsules inwards 
    YUSB Farma S.A.     Belgium
  • Nootropil®
    solution w / m in / in d / infusion 
    YUSB Farma S.A.     Belgium
  • Nootropil®
    solution inwards 
    YUSB Farma S.A.     Belgium
  • Nootropil®
    pills inwards 
    YUSB Farma S.A.     Belgium
  • Pyracetam
    solution w / m in / in 
    ORGANICS, JSC     Russia
  • Pyracetam
    pills inwards 
    ORGANICS, JSC     Russia
  • Pyracetam
    pills inwards 
    MARBIOFARM, OJSC     Russia
  • Pyracetam
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    DALHIMFARM, OJSC     Russia
  • Pyracetam
    solution w / m in / in 
    VEROPHARM SA     Russia
  • Pyracetam
    solution w / m in / in 
    Mapichem AG     Switzerland
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    solution in / in d / infusion 
    Company DEKO, LLC     Russia
  • Pyracetam
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pyracetam
    capsules inwards 
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    capsules inwards 
    FARMPROJECT, CJSC     Russia
  • Pyracetam
    capsules inwards 
    ATOLL, LLC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    BIOCHEMIST, OJSC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    ELLARA, LTD.     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    SYNTHESIS, OJSC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    ATOLL, LLC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    BIOSINTEZ, PAO     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
  • Pyracetam
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Pyracetam
    capsules inwards 
    VERTEKS, AO     Russia
  • Pyracetam
    capsules inwards 
    AKRIKHIN HFK, JSC     Russia
  • Pyracetam
    solution w / m in / in d / infusion 
    GROTEKS, LLC     Russia
  • Pyracetam
    solution in / in d / infusion 
  • Pyracetam
    pills inwards 
    IRBITSK HFZ, OJSC     Russia
  • Pyracetam
    capsules inwards 
  • Pyracetam
    pills inwards 
  • Pyracetam
    capsules inwards 
    URALBIOFARM, OJSC     Russia
  • Pyracetam
    capsules inwards 
    MINSKINTERKAPS, UP     Republic of Belarus
  • Pyracetam
    capsules inwards 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Pyracetam
    solution w / m in / in d / infusion 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Pyracetam
    solution in / in d / infusion 
  • Pyracetam
    pills inwards 
    OZONE, LLC     Russia
  • Pyracetam
    capsules inwards 
  • Pyracetam
    capsules inwards 
    NGO Farmvilar, OOO     Russia
  • Pyracetam of Avexime
    pills inwards 
  • Pyracetam Beefus
    solution w / m in / in d / infusion 
    UPDATE OF PFC, CJSC     Russia
  • Pyracetam Welfarm
    solution w / m in / in 
    VELFARM, LLC     Republic of San Marino
  • Piracetam MS
    pills inwards 
    MEDISORB, CJSC     Russia
  • Pyracetam Obolenskoe
    pills inwards 
  • Piracetam-Vial
    solution w / m in / in d / infusion 
    VIAL, LLC     Russia
  • Piracetam-Richter
    pills inwards 
  • Piracetam-SZ
    capsules inwards 
    NORTH STAR, CJSC     Russia
  • Piracetam-Ferein®
    solution w / m in / in d / infusion 
    BRYNTSALOV-A, CJSC     Russia
  • Piracetam-Ferein®
    capsules inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Piracetam-Eskom
    solution w / m in / in d / infusion 
    ESKOM NPK, OAO     Russia
  • The escotropel
    solution in / in d / infusion 
    ESKOM NPK, OAO     Russia
  • The escotropel
    solution in / in d / infusion 
    ESKOM NPK, OAO     Russia
  • Dosage form: & nbspCapsules.
    Composition:

    One capsule contains 0.4 g of piracetam. Excipients: calcium stearate, magnesium carbonate basic.

    Description:

    Capsules of white and orange color No. 0 or No. 1. The contents of the capsules are white or almost white powder.

    Pharmacotherapeutic group:Nootropic agent.
    ATX: & nbsp

    N.06.B.X.03   Pyracetam

    Pharmacodynamics:

    Pyracetam is a nootropic agent, it has a positive effect on the metabolic processes of the brain. Increases the concentration of ATP in the brain tissue, enhances the synthesis of ribonucleic acid and phospholipids, stimulates glycolytic processes, increases the utilization of glucose. Pyracetam improves the integrative activity of the brain, improves memory, has a protective effect in various forms of cerebral hypoxia, facilitates the learning process. The drug improves the connections between the cerebral hemispheres and synaptic conductivity in the neocortical structures, improves and stabilizes the cerebral functions (especially memory and speech), increases mental performance.

    Pharmacokinetics:

    After ingestion, it is well absorbed and penetrates into various organs and tissues. Bioavailability, regardless of the dosage form, is about 95%. The time to reach the maximum concentration in the blood plasma is 30-60 minutes. Penetrates through the blood-brain barrier, accumulates in the brain tissue 1-4 hours after ingestion. From the cerebrospinal fluid is derived much more slowly than from other tissues. Virtually not metabolized. It is excreted by the kidneys.

    Indications:

    Piracetam is used in neurological, psychiatric and narcological practices.

    In neurological practice: cerebrovascular diseases of the brain with the phenomena of chronic cerebrovascular insufficiency,manifested in violations of memory, attention, speech, dizziness and headache; disorders of cerebral circulation: states after traumas and intoxications of the brain, as well as in the period of residual phenomena of these conditions with the purpose of increasing the motor and mental activity of patients. Pyracetam also used in patients with diseases of the nervous system, accompanied by a decrease in intellectual-mnestic functions and disorders of the emotional-volitional sphere.

    In psychiatric practice: neurotic depressive states of various genesis with prevalence in the clinical picture of signs of adynamia, asthenic and senesto-hypochondriacal disorders, phenomena of ideomotor inhibition; sluggish-apathetic defective states in senile and atrophic processes; complex therapy of mental illnesses occurring on "organically inferior soil". As an aid in the treatment of depressive diseases resistant to antidepressants, as well as with poor tolerability of antipsychotics and other psychotropic drugs in order to eliminate or prevent the somatovegetative ones caused by them.neurological or psychiatric complications. As an aid piracetam can be used for epilepsy.

    In narcological practice: complex therapy for relief of abstinent conditions in alcoholism and drug addiction. Besides, piracetam apply in the treatment of chronic alcoholism with the phenomena of persistent mental disorders (asthenia, intellectual-mnestic disorders, etc.).

    Indications in children. If necessary, accelerate the learning process and eliminate the effects of perinatal brain damage caused by intrauterine infections, hypoxia, birth trauma, oligophrenia, mental retardation, cerebral palsy.

    Contraindications:

    Individual intolerance of the drug: acute renal failure, acute phase of hemorrhagic stroke, depression with anxiety (agitated depression), Huntington's disease; pregnancy and lactation

    Carefully:

    Pyracetam is used with caution in cases of hemostasis disorders, extensive surgical interventions, severe bleeding.

    Dosing and Administration:

    In the treatment of acute conditions are used inside after the course of parenteral treatment with the drug. In the treatment of chronic conditions piracetam usually, starting with a daily dose of 1.2 g (0.4 g 3 times per day) and adjusted to 2.4 grams, sometimes up to 3.2 grams or more. The therapeutic effect in these cases is noted, as a rule, 2-3 weeks after the start of treatment. Subsequently, the dose is reduced to 1.2-1.6 g (0.4 g 3-4 times a day). The course of treatment continues from 2-3 weeks to 2-6 months. If necessary, repeat the treatment. Treatment with pyracetamol, if necessary, can be combined with the use of psychotropic, cardiovascular and other drugs.

    This dosage form is recommended for children from 5 years - 1 capsule 3 times a day. The maximum daily dose is 1.8 g. The course of treatment: from 2 weeks to 2-6 months.

    Side effects:

    When using piracetam, there may be a decrease in appetite, increased irritability, agitation, increased sexual activity, sleep disturbance, headache, dizziness, convulsions, tremor, dyspeptic disorders, increased motor activity, in elderly patients, coronary insufficiency deteriorates occasionally. In these cases, you should reduce the dose or stop taking the drug.Side effects are most often observed at doses above 5 g / day.

    In children, especially with mental retardation: fussiness, decreased ability to concentrate, anxiety, restlessness, motor disinhibition, imbalance, increased conflict.

    Overdose:

    In case of an overdose, there may be an increase in possible side effects. First aid - washing the stomach, taking activated carbon.

    Interaction:

    Simultaneous use of piracetam with drugs that stimulate the central nervous system. strengthen their effects, with neuroleptics, their central effect (tremor, anxiety, etc.) increases. Pyracetam enhances the effect of oral anticoagulants. Increases the effectiveness of thyroid hormones, neuroleptics, psychostimulants. When administered with neuroleptics reduces the risk of extrapyramidal disorders.

    Special instructions:

    When taking pyracetam, periodic monitoring of renal function indicators is recommended (especially in patients with chronic renal insufficiency) - residual nitrogen and creatinine, and in patients with liver diseases - the functional state of the liver.

    In the treatment of patients with cortical myoclonia, abrupt withdrawal of the drug should be avoided (risk of resumption of seizures).

    If there is a disturbance in sleep, it is recommended to cancel the evening reception, adding this dose to the morning and evening dosages.

    Effect on the ability to drive transp. cf. and fur:

    During the treatment period it is necessary to refrain from driving motor vehicles and practicing potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions

    Form release / dosage:

    Capsules 0.4 g.

    Packaging:

    For 10 or 20 capsules in a can of orange glass or a plastic container or bottle;

    10 or 15 capsules in a contour cell package.

    A can, a plastic container, a bottle, 1, 2, 6 contour packs of 10 capsules or 4 contourcell packs of 15 capsules together with instructions for use in a pack of cardboard.

    Storage conditions:List B. In a dry, protected from light and inaccessible to children place.
    Shelf life:

    3 years. Do not use after the time specified on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:P N000577 / 02
    Date of registration:15.08.2008
    The owner of the registration certificate:BRYNTSALOV-A, CJSC BRYNTSALOV-A, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp23.09.2015
    Illustrated instructions
      Instructions
      Up